POSTER SESSION IV
Tuesday, March 23, 2010   —  1:00 PM - 4:30 PM
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GASTROINTESTINAL PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
55 Immunohistochemistry for SDHB Distinguishes Carney Triad and Carney-Stratakis Syndrome Associated GISTs (Type 2 GISTs) from Usual Sporadic GISTs (Type 1 GISTs) (643)
AJ Gill, A Chou, A Clarkson, RP Eckstein, A Shi, C Smith, L Siosson, DE Benn, RJ Clifton-Bligh - Royal North Shore Hospital, Pacific Highway, St Leonards, Australia; Kolling Institute of Medical Research Royal North Shore Hospital and University of Sydney, Sydney, NSW, Australia 		Add
56 PCHK2 Is Associated with Differentiation and Survival in Gastric Adenocarcinoma (723)
JB Rock, IS Hatzaras, M Bloomston, K Huebner, WL Frankel - The Ohio State University, Columbus, OH 		Add
57 PEComas of the Gastrointestinal Tract and Mesentery: Clinicopathologic Study of 25 Cases with Evaluation of Prognostic Parameters (654)
JL Hornick, CDM Fletcher - Brigham & Women's Hospital, Boston, MA 		Add
58 Evidence That Dysplasia Begins in the Bases of the Pits in the Pathogenesis of Gastric Cancer (593)
AT Agoston, GY Lauwers, RD Odze - Brigham & Womens Hospital and Massachusetts General Hospital, Boston, MA 		Add
59 Gastric Foveolar Hyperplasia, Foveolar Dysplasia and Pit Dysplasia in 414 Gastric Cancers-Prevalence and Clinicopathological Significance (708)
DY Park, HJ Kang, DH Shin, KU Choi, CH Lee, GY Huh, MY Sol, GY Lauwers - Pusan National University Hospital, Busan, Republic of Korea; Massachusetts General Hospital and Harvard Medical School, Boston, MA 		Add
60 PAS Is Superior to H&E for Screening Prophylactic Gastrectomies from CDH1 Mutation Carriers (676)
AF Lee, H Rees, DA Owen, DG Huntsman - University of British Columbia, Vancouver, BC, Canada; Saskatoon City Hospital, Saskatoon, SK, Canada; Vancouver General Hospital, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada 		Add
61 Pathological Response after Neoadjuvant Treatment in Advanced Gastric Cancer: Impact on Survival (741)
JJ Sola, C Beorlegui, A Panizo, FJ Pardo, G Aisa, JA Diaz-Gonzalez, JL Hernandez, J Aristu, MA Idoate - Clinica Universidad de Navarra, Pamplona, Navarra, Spain 		Add
62 Metastatic Lymph Node Ratio in Advanced Gastric Carcinoma: A Better Prognostic Factor Than Number of Metastatic Lymph Nodes? (677)
SY Lee, IS Hwang, YS Park, J Gardner, JY Ro - University of Ulsan College of Medicine, Asan Medical, Center, Seoul, Democratic Peoples Republic of Korea; University of Keimyung College of Medicine, Daegu, Democratic Peoples Republic of Korea; The Methodist Hospital, Weill Medical College, Cornell University, Houston, TX 		Add
63 CpG Island Hypermethylation in Gastric Carcinoma and Its Clinicopathological Implication (710)
SY Park, MC Kook, YW Kim, NY Cho, GH Kang - National Cancer Center, Goyang-si, Korea; Seoul National University College of Medicine, Seoul, Korea 		Add
64 Expression of the microRNA-200 Family; a New Role for miRNAs in the Morphological Changes of Epstein-Barr Virus Associated Gastric Carcinoma (729)
T Sakatani, A Shinozaki, T Ushiku, M Isogai, S Ishikawa, H Uozaki, M Fukayama - The University of Tokyo, Tokyo, Japan 		Add
65 Expression of Stem Cell Markers in Human Gastric Adenocarcinoma and Non-Neoplastic Gastric Mucosa, a Study of 209 Cases (633)
S Dhingra, W Feng, D Zhou, T Khoury, RE Brown, D Tan - MD Anderson Cancer Center and UT Health Science Center, Houston, TX; University of Rochester, Rochester; Roswell Park Cancer Institute, Buffalo, NY 		Add
66 Expression of Aldehyde Dehydrogenase Is Associated with High-Grade Histology and Poor Survival in Patients with Primary Small Bowel Adenocarcinomas (706)
ML Othman, A Rashid, JL Abbruzzese, RA Wolff, H Wang - MD Anderson Cancer Center, Houston, TX 		Add
67 Overexpression of X-Linked Inhibitor of Apoptosis Protein in Gastrointestinal Dsyplasia and Adenocarcinoma (642)
K Gilbert-Lewis, J Heitzman, W Feng, W Li - University of Texas Health Science Center at Houston, Houston, TX 		Add
68 "In Situ" Growth of Metastatic Tumors to the Gastrointestinal Tract: A Potential Mimic of Primary Neoplasia (637)
JS Estrella, A Rashid, SC Abraham - MD Anderson Cancer Center, Houston 		Add
69 Her2 Status in Small Intestinal Adenocarcinoma (618)
OTM Chan, Z Chen, DC Phan, E Himmelfarb, HL Wang - Cedars-Sinai Medical Center, Los Angeles, CA; Northwestern University Feinberg School of Medicine, Chicago, IL 		Add
70 Expression of Mismatch Repair Genes, HMLH1, HMSH2 and HMSH6 in 195 Small Intestinal Adenocarcinomas (745)
WJ Sung, YK Bae, S-M Hong, The Korean Small Intestinal Cancer Study Group - Yeungnam University College of Medicine, Daegu, Korea; Johns Hopkins Medical Institutions, Baltimore, MD 		Add
71 Is Proximal Microvesicular Serrated Polyp the Precursor of Sessile Serrated Adenoma of the Colon? (761)
H Xu, S Yang, O Adjapong, MJ O'Brien - Boston University School of Medicine, Boston, MA 		Add
72 Tumor Thickness at Tumor-Normal Interface: A Novel Pathologic Indicator of Chemotherapy Response in Hepatic Colorectal Metastases (592)
A Agarwal, S Kopetz, P Boonsirikamchai, YS Chun, H Wang, JN Vauthey, EM Loyer, DM Maru - MD Anderson Cancer Center, Houston 		Add
73 KRAS Mutations Are Associated with Specific Morphologic Features in Colon Cancer (646)
A Gunal, B Kenney, P Hui, S Kilic, R Xu, D Jain, K Mitchell, M Robert - Gulhane Military Medical School, Ankara, Turkey; Yale University School of Medicine, New Haven, CT; New York University School of Medicine, New York, NY 		Add
74 Ipilimumab Induced Enterocolitis: A Clinico-Pathologic Study (666)
B Kenney, C Loeser, M Sznol, H Kluger, D Jain, K Mitchell - Yale University School of Medicine, New Haven, CT 		Add
75 Lymphoid Reaction to Colorectal Cancer Predicts Patient Survival Independent of Lymph Node Count and MSI, and Explains the Association between CIMP and Good Prognosis (701)
S Ogino, K Nosho, JN Glickman, M Mino-Kenudson, CS Fuchs - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Massachusetts General Hospital, Boston, MA 		Add
76 Loss of PPARG Expression Is Common in CpG Island Methylator Phenotype-low Colorectal Cancer (738)
K Shima, K Nosho, L Chen, CS Fuchs, S Ogino - Dana-Farber Cancer Institute, Boston, MA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA 		Add
77 Overexpression of Transcription Intermediary Factor 1 γ Is an Early Event in Colorectal Carcinogenesis and Inversely Related to Smad4 Inactivation in Colorectal Carcinoma (658)
S Jain, M Yu, S Singhal, F Francis,, C Hajdu, S Suriawinata, M Zhang, N Aladhamy, L Chiriboga, R Pan, P Lee, J Wang, R Xu - New York University School of Medicine, New York, NY; Brooklyn Hospital Center, Brooklyn, NY; Dartmouth-Hitchcock Medical Center, Lebanon, NH; NYU School of Medicine, New York, NY 		Add
78 The Loss/Decreased Expression of GPR43 in Colorectal Carcinogenesis: A Highly Possible Tumor Suppressor Gene and Novel Therapeutic Target (687)
KA Matkowskyj, J Liao, H Li, SM Rao, G-Y Yang - Northwestern University, Chicago, IL 		Add
79 KRAS Mutation Analysis in Colonic Adenocarcinomas: Correlation between Biopsy and Resection Specimens (733)
JF Schmidt, G Soucy, RD Odze, L Dejesa-Jamanila, K Arnold, Q Yang, C Kuslich, RH Lash - Caris Diagnostics, Irving, TX; Brigham & Women's Hospital, Boston, MA; Caris Diagnostics, Phoenix, AZ 		Add
80 Treated Rectal Adenocarcinomas Are Associated with Increased Expression of CK20 and Chromogranin (607)
AM Bellizzi, CD Crowder, WL Marsh, H Hampel, WL Frankel - The Ohio State University Medical Center, Columbus, OH; Brigham and Women's Hospital, Boston, MA 		Add
81 The Use of Molecular Markers as a Method of Predicting Response to Combined Modality Therapy for Advanced Stage Rectal Cancers (608)
ME Berho, SD Wexner - Cleveland Clinic Florida, Weston, FL 		Add
82 Evaluation of Epidermal Growth Factor Receptor Expression and Gene Amplification in Colorectal Carcinoma: An Immunohistochemical and Chromogenic In Situ Hybridization Study Using Tissue Microarray (728)
RS Saad, C Rowsell, MA Khalifa - Sunnybrook Health Sciences Center/University of Toronto, Toronto, ON, Canada 		Add
83 Colorectal Granular Cell Tumor; a Study of 24 Cases (740)
AD Singhi, E Montgomery - Johns Hopkins Hospital, Baltimore, MD 		Add
84 Correlation of KRAS Mutation and Villous Adenoma in Colorectal Adenocarcinoma Guides Pretreatment Screening and Targeted Therapy (619)
H Chen, JA Lefferts, GJ Tsongalis, A Suriawinata - Dartmouth-Hitchcock Medical Center, Lebanon, NH 		Add
85 Lynch Syndrome Screening in a Series of 869 Prospective Colorectal Carcinomas (697)
E Musulen, C Sanz, A Munoz-Marmol, L Benito, JL Mate, A Ariza - Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Institut Catala d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain 		Add
86 Assessment of Molecular Biomarkers To Predict Response to Chemoradiation in Rectal Adenocarcinomas: A Tissue Microarray Based Study (663)
P Kapur, D Saha, S Huerta - UT Southwestern Medical Center, Dallas, TX 		Add